Sotera Health Co (SHC)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 6.65 | 6.58 | 6.24 | 6.97 | 7.38 | 6.99 | 6.81 | 7.60 | 7.86 | ||||
| DSO | days | 54.87 | 55.51 | 58.47 | 52.37 | 49.44 | 52.20 | 53.62 | 48.01 | 46.43 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 6.65
= 54.87
The Days of Sales Outstanding (DSO) for Sotera Health Co have shown some fluctuations over the past eight quarters. In Q4 2023, the DSO was 53.37 days, slightly lower than the DSO of 53.42 days in Q3 2023. The DSO peaked at 56.87 days in Q2 2023 before decreasing to 50.25 days in Q1 2023. Comparing these figures to the same quarters in the previous year, there has been a noticeable increase in DSO, with Q4 2022 at 47.49 days, Q3 2022 at 50.32 days, Q2 2022 at 51.60 days, and Q1 2022 at 45.99 days.
Overall, the trend indicates a slight increase in the DSO from the previous year, which may suggest potential challenges in collecting accounts receivable within the company's standard credit terms. It is important for Sotera Health Co to closely monitor and manage its DSO to ensure efficient cash flow management and timely collection of outstanding receivables.
Peer comparison
Dec 31, 2023